1. A Novel Small Molecular Antibody, HER2-Nanobody, Inhibits Tumor Proliferation in HER2-Positive Breast Cancer Cells In Vitro and In Vivo
   Yan Yan et al, 2021, Frontiers in Oncology CrossRef
2. Bifunctional bioplatform based on NiCo Prussian blue analogue: Label-free impedimetric aptasensor for the early detection of carcino-embryonic antigen and living cancer cells
   Linghao He et al, 2019, Sensors and Actuators B: Chemical CrossRef
3. Immuno-PET of colorectal cancer with a CEA-targeted [68 Ga]Ga-nanobody: from bench to bedside
   Liqiang Li et al, 2023, European Journal of Nuclear Medicine and Molecular Imaging CrossRef
4. “Nanobody-based immunodiagnostics: A systematic review of nanobody integration in diagnostics and deep insight into electrochemical immunoassays”
   Mohammad IA. Ahmad et al, 2024, Microchemical Journal CrossRef
5. Radionuclide-based theranostics — a promising strategy for lung cancer
   Tianxing Zhu et al, 2023, European Journal of Nuclear Medicine and Molecular Imaging CrossRef
6. Single-Domain Antibodies and the Promise of Modular Targeting in Cancer Imaging and Treatment
   María Elena Iezzi et al, 2018, Frontiers in Immunology CrossRef
7. Engineering Nanobody Targeting Cancer Stem Cells
   Md Sajedul Islam et al, 2023, Cancer Stem Cells: Basic Concept and Therapeutic Implications CrossRef
8. Single-domain antibodies for radio nuclear imaging and therapy of esophageal squamous cell carcinoma: a narrative review
   Huifang Liu et al, 2020, Journal of Bio-X Research CrossRef
9. Radiolabeled nanobodies for tumor targeting: From bioengineering to imaging and therapy
   Majid Piramoon et al, 2021, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
10. Nanobody: A Small Antibody with Big Implications for Tumor Therapeutic Strategy
    Shuyang Sun et al, 2021, International Journal of Nanomedicine CrossRef
11. Generation and Application of Fluorescent Anti-Human β2-Microglobulin VHHs via Amino Modification
    Chundong Huang et al, 2019, Molecules CrossRef
12. Targeted cancer therapy through antibody fragments-decorated nanomedicines
    Abbas Alibakhshi et al, 2017, Journal of Controlled Release CrossRef
13. Research Progress and Applications of Multivalent, Multispecific and Modified Nanobodies for Disease Treatment
    Jiewen Wang et al, 2022, Frontiers in Immunology CrossRef
14. Assessment of the Efficacy and Clinical Utility of Different Circulating Tumor Cell (CTC) Detection Assays in Patients with Chemotherapy-Naïve Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
    Maria A. Papadaki et al, 2021, International Journal of Molecular Sciences CrossRef
15. Promising Diagnostic and Therapeutic Approaches Based on VHHs for Cancer Management
    Ying Cong et al, 2024, Cancers CrossRef
16. An Efficient Method for Labeling Single Domain Antibody Fragments with 18F Using Tetrazine-Trans-Cyclooctene Ligation and a Renal Brush Border Enzyme-Cleavable Linker
    Zhengyuan Zhou et al, 2018, Bioconjugate Chemistry CrossRef
17. Nanobodies in cancer
    Elisha R. Verhaar et al, 2021, Seminars in Immunology CrossRef
18. Ministry of Health Data Reveals Age, Gender, and Clinic-specific Differences in CEA Test Outcomes for Colorectal Cancer Detection
    Şuayıp Birinci, 2023, Journal of Academic Research in Medicine CrossRef
19. Evolving therapeutic proteins to precisely kill cancer cells
    Rahela Zaman et al, 2022, Journal of Controlled Release CrossRef